Search - tctmd.com

Displaying 541 - 560 of 2476

Sort: Relevancy | Date

News Daily News

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

Caitlin E. Cox

October 06, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Daily News

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

Todd Neale

October 03, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2023

Shelley Wood

October 03, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

MESA Data Can Lend Context to Incidental CAC Findings

Yael L. Maxwell

September 29, 2023

News Daily News

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

Michael O'Riordan

September 29, 2023

News Daily News

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Shelley Wood

September 28, 2023

News Daily News

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

Michael O'Riordan

September 21, 2023

News Daily News

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

L.A. McKeown

September 20, 2023

News Daily News

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

L.A. McKeown

September 18, 2023

News Daily News

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

Michael O'Riordan

September 15, 2023

News Daily News

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Michael O'Riordan

September 13, 2023

News Daily News

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

Todd Neale

September 12, 2023

News Conference News ESC 2023

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

Michael O'Riordan

September 06, 2023

News Conference News ESC 2023

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

Michael O'Riordan

September 05, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

L.A. McKeown

September 01, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

Advertisement

Major GI Events Rare but Real in Weight-Loss Patients on GLP-1 Drugs

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke

TCTMD’s Top 10 Most Popular Stories for September 2023

October 2023 News Roundup

MESA Data Can Lend Context to Incidental CAC Findings

PET-Guided Strategy Lowers Risk, Boosts Outcomes in Stable CAD: CENTURY

GLP-1 Meds Linked to 265 Reports to FDA of Suicidal Ideation: Reuters

Angiogram-Derived Functional Tests Pre-TAVI: Simpler, Yes, but Warranted?

AHA Updates Advice for Resuscitation, CV Care After Overdose or Poisons

‘Overwhelming Reduction’ in Bleeding With Abelacimab vs Rivaroxaban in AF

European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba

‘Functional’ SYNTAX Score May Hone PCI, CABG Choices in Multivessel Disease

Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle

ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More

ESC/EACTS Task Force Recommends Downgrading PCI in Left Main CAD

TCTMD’s Top 10 Most Popular Stories for August 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

September 2023 News Roundup

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content